Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis

被引：0
|
作者：
Wei Liu
Qian Zhang
Tiantian Zhang
Li Li
Chunhua Xu
机构：
[1] Affiliated Nanjing Brain Hospital,Department of Respiratory Medicine
[2] Nanjing Medical University,undefined
[3] Clinical Center of Nanjing Respiratory Diseases and Imaging,undefined
来源：
World Journal of Surgical Oncology | / 20卷
关键词：
PD-1/PD-L1 inhibitors; Chemotherapy; Quality of life; Non-small cell lung cancer; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Comparative efficacy and safety of PD-1/PD-L1 immunotherapies for non-small cell lung cancer: a network meta-analysis
    Wang, D-D
    Shaver, L. G.
    Shi, F-Y
    Wei, J-J
    Qin, T-Z
    Wang, S-Z
    Kong, Y. J.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2866 - 2884
  • [32] Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis
    Guo, Xiaodi
    Li, Wendong
    Hu, Jiexuan
    Zhu, Emily C.
    Su, Qiang
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (10) : 1345 - 1354
  • [33] Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis
    Xiaodi Guo
    Wendong Li
    Jiexuan Hu
    Emily C. Zhu
    Qiang Su
    [J]. European Journal of Clinical Pharmacology, 2020, 76 : 1345 - 1354
  • [34] Efficacy and safety of PD-1/PD-L1 inhibitors in elderly patients with advanced non-small cell lung cancer
    Li, Li
    Xu, Chunhua
    Wang, Wei
    Zhang, Qian
    [J]. CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05):
  • [35] Gender Differences and Their Effects on Survival Outcomes in Lung Cancer Patients Treated With PD-1/PD-L1 Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
    Madala, S.
    Rasul, R.
    Singla, K.
    Sison, C. P.
    Seetharamu, N.
    Castellanos, M. R.
    [J]. CLINICAL ONCOLOGY, 2022, 34 (12) : 799 - 809
  • [36] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
    Shankar, Bairavi
    Naidoo, Jarushka
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
  • [37] Research progression of PD-1/PD-L1 in non-small cell lung cancer
    Xing Liu
    Xiaodong Xie
    [J]. Oncology and Translational Medicine, 2017, 3 (03) : 111 - 115
  • [38] The efficacy and safety of PD-1/PD-L1 inhibitors in breast cancer: a systematic review and meta-analysis
    Xiao, Bo-Ya
    Lin, Guo-He
    Zhao, Yan-Xia
    Wang, Bi-Cheng
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (06) : 3804 - 3818
  • [39] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
    Kumar, Rajiv
    Collins, Dearbhaile
    Dolly, Saoirse
    McDonald, Fiona
    O'Brien, Mary E. R.
    Yap, Timothy A.
    [J]. CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
  • [40] PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review
    Dai, Yun
    Muaibati, Munawaer
    Xie, Weiming
    Abasi, Abuduyilimu
    Li, Kexin
    Tong, Qing
    Zhang, Tao
    Meng, Yifan
    Zhuang, Liang
    Huang, Xiaoyuan
    [J]. CANCER INVESTIGATION, 2022, 40 (03) : 293 - 309
12345